Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
»
Bristol, AstraZeneca among Amylin bidders-sources
Interactive Investor
Sun, 06/3/12 - 12:23 pm
Bristol-Myers Squibb
AstraZeneca
Amylin
M&A
RSI Alert For Top-Ranked Teva Pharmaceutical Industries
Forbes
Sun, 06/3/12 - 12:21 pm
Teva Pharmaceuticals
Teva chairman buys 1 mln shares of drugmaker
Reuters
Sun, 06/3/12 - 11:40 am
Teva Pharmaceuticals
Actos again tied to bladder cancer risk
FiercePharma
Sun, 06/3/12 - 11:39 am
Actos
bladder cancer
Takeda
€224 million EU antibiotics initiative launched
RSC
Sun, 06/3/12 - 11:38 am
antibiotics
Aeolus Pharmaceuticals Announces AEOL 10150 Reduces Lung Damage After Neupogen(R) Treatment Following Radiation Exposure
equities.com
Sun, 06/3/12 - 11:37 am
Aeolus Pharmaceuticals
AEOL 10150
Forest Laboratories and Nabriva sign development agreement for anti-bacterial drug
Proactive Investors
Sun, 06/3/12 - 11:34 am
Nabriva Therapeutics
Forest Labs
BC-3781
antibiotics
Study: Hormone pill slows prostate cancer's growth
Yahoo/AP
Sun, 06/3/12 - 11:19 am
Zytiga
JNJ
prostate cancer
Bristol-Myers Immune Drug Puts Deadly Cancers on Hold in Study
Bloomberg
Sun, 06/3/12 - 11:18 am
skin cancer
Bristol-Myers Squibb
BMS-936558
kidney cancer
lung cancer
Human Genome Sciences: Poison Pills Can Kill You If Your Suitor Walks Away
Seeking Alpha
Sun, 06/3/12 - 11:15 am
Human Genome Sciences
3 Biotech Stocks Outperforming On Insider, Hedge Fund Buying
Seeking Alpha
Sun, 06/3/12 - 11:14 am
Theravance
Repros Therapeutics
Ziopharm
Study: 'Smart bomb' drug attacks breast cancer
Yahoo/AP
Sun, 06/3/12 - 11:13 am
T-DM1
breast cancer
Genentech
Roche
Results from a Randomized Study of REVLIMID® (Lenalidomide) and Rituximab (R2) in Patients with Recurrent Follicular Lymphoma Presented at ASCO
Yahoo/Business Wire
Sun, 06/3/12 - 11:10 am
Revlimid
rituximab
follicular lymphoma
Cellgene
Cabozantinib Demonstrates Encouraging Activity in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma
Yahoo/Business Wire
Sun, 06/3/12 - 11:09 am
cabozantinib
renal cell carcinoma
Exelixis
The Market Is Wrong About Vertex
Motley Fool
Sun, 06/3/12 - 11:08 am
Vertex Pharmaceuticals
Puma Biotechnology presents positive PB272 clinical data at ASCO
Yahoo/The Fly On The Wall
Sun, 06/3/12 - 11:07 am
Puma Biotechnology
PB272
breast cancer
Oncothyreon Announces Presentation of PX-866 Clinical Data at American Association of Clinical Oncology Annual Meeting
Yahoo/PR NewsWire
Sun, 06/3/12 - 11:06 am
PX-866
Oncothyreon
non-small cell lung cancer
squamous cell cancer
Reliv Announces Breakthrough in Fight Against Metabolic Syndrome
Yahoo/PR NewsWire
Sun, 06/3/12 - 11:02 am
Reliv
metabolic syndrome
GlucAffect
LunaRich
Plan to Speed Up FDA Reviews Recently Approved by Senate
Fri, 06/1/12 - 11:01 pm
FDA
congress
government
Axiom Announces Key Staff Appointment in Sales
Fri, 06/1/12 - 10:59 pm
Axiom
sales
Management
Pages
« first
‹ previous
…
3205
3206
3207
3208
3209
3210
3211
3212
3213
…
next ›
last »